Thursday, January 29, 2026 | 04:42 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Piramal Pharma Share Price

Know More
BSENSE

166.35-24.15 (-12.68%)

16-Jan-2026
Stock not traded

BSE : 543635

NSE : PPLPHARMA

Sector : Health care

ISIN Code : INE0DK501011

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 16-Jan-2026

Market Cap (₹ Cr)

22,054

Traded Value (₹ Cr)

1.86

Volume (Shares)

1,11,761

Face Value (₹)

10

52-Week High (₹)

252.05

52-Week High Date

23-Jan-2025

52-Week Low (₹)

163.70

52-Week Low Date

12-Jan-2026

All Time High (₹)

307.85

All Time High Date

06-Nov-2024

All Time Low (₹)

61.65

All Time Low Date

28-Mar-2023

Piramal Pharma Ltd

Piramal Pharma Limited was incorporated on March 4 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO busi...
Read More

Piramal Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

22,054

EPS - TTM (₹) [C]

-0.18

P/E Ratio (X) [C]

-924.17

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) 0.08
Book Value Share (₹) [C]60.77
P/B Ratio (₹) [C]2.74

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HDFC Flexi Cap Fund - (IDCW) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - (G) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - Direct (IDCW) 1542.15 8,12,12,856 2.40
HDFC Flexi Cap Fund - Direct (G) 1542.15 8,12,12,856 2.40
HDFC Focused Fund - Regular (G) 436.75 2,30,00,000 2.81
HDFC Focused Fund - Regular (IDCW) 436.75 2,30,00,000 2.81
HDFC Focused Fund - Direct (IDCW) 436.75 2,30,00,000 2.81
HDFC Focused Fund - Direct (G) 436.75 2,30,00,000 2.81
Franklin India Opportunities Fund - (G) 64.71 34,07,626 1.17
Franklin India Opportunities Fund - Direct (G) 64.71 34,07,626 1.17

Load more

Research Reports

DateBrokerActionPrices(₹) Report
25-Sep-2024Motilal Oswal Buy 260

Stock Strength

Today's Low/High (₹)

165.20

169.10

Week Low/High (₹)

99.15

169.10

Month Low/High (₹)

99.15

169.10

Year Low/High (₹)

163.70

252.00

All time Low/High (₹)

61.65

308.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week61.66%62.32%40.85%45.95%
1 Month34.15%34.75%36.34%40.93%
3 Month-5.02%-4.60%37.37%42.33%
6 Month--43.22%47.77%
1 Year--42.16%46.32%
3 Year--109.59%119.46%

Company Info

Company Information

Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000

Email:corporate.secretarial@piramal.com

URL:http://www.piramal.com

FAQs about Piramal Pharma Ltd

1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 166.35 at close on 16th Jan 2026. Piramal Pharma Ltd share price was down by 12.68% from the previous closing price of Rs 190.50. Piramal Pharma Ltd share price trend:

  • Last 1 Month: Piramal Pharma Ltd share price moved up by 34.15% on BSE.
  • Last 3 Months: Piramal Pharma Ltd share price moved down by 5.02% on BSE.


2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is -924.17
  • Price to book value ratio is 2.74
  • Dividend yield of 0.08
  • The EPS (trailing 12 months) of the Piramal Pharma Ltd stock is Rs -0.18


3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 22,054 crore.


4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 252.05 and 52-week low share price is Rs 163.70.


5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a profit of Rs 3.68 crore on a total income of Rs 2,233.40 crore for the quarter ended 2024.


6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Emcure Pharma, Gland Pharma, Wockhardt, Piramal Pharma, Pfizer, Astrazeneca Phar, ERIS Lifescience.


7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows:

  • Promoter holding in Piramal Pharma Ltd has gone up to 34.79 per cent as of Dec 2022 from 34.79 per cent as of Sep 2022.